Clinical Trials

NCT IdNCT04108091
TitleVyndaqel Capsules Special Investigation (ATTR-CM)
ConditionTransthyretin (TTR) Amyloid Cardiomyopathy
StudyTypeObservational
OrganizationPfizer
Sponsor/CollaboratorsPfizer
StatusRecruiting
GenderAll
AgeGroupChild
Adult
Older Adult
Location (with distance)
  • Pfizer, Tokyo, Japan
DescriptionSecondary Data Collection : To confirm the safety and effectiveness profiles under the actual medical practice of Vyndaqel in Japan.